Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease

被引:29
作者
Kimura, K [1 ]
Moriwaki, H
Nagaki, M
Saio, M
Nakamoto, Y
Naito, M
Kuwata, K
Chisari, FV
机构
[1] Gifu Univ, Ctr Emerging Infect Dis, Gifu 5011194, Japan
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
[3] Gifu Univ, Sch Med, Dept Internal Med 1, Gifu 5011194, Japan
[4] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu 5011194, Japan
[5] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 920, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata, Japan
关键词
D O I
10.2353/ajpath.2006.050314
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Activated B cells function in antibody production and antigen presentation, but whether they perform any pathophysiological functions at sites of inflammation is not fully understood. Here, we report that intravenous injection of an agonistic anti-CD40 monoclonal antibody (alpha CD40) causes a biphasic inflammatory liver disease in inbred mice. The late phase of disease was suppressed in B-cell-deficient mice and by the depletion of macrophages, but not T cells or natural killer cells. We also report that SCID mice were not susceptible to alpha CD40-induced liver disease unless they were reconstituted with normal B cells and that B cells as well as macrophages played key roles in alpha CD40-induced late phase of liver inflammation. Finally, liver disease and the recruitment of inflammatory cells into the liver were mediated by interferon-gamma and tumor necrosis factor-alpha, but not by Fas. In conclusion, these results indicate that CD40 ligation can trigger a B-cell-mediated inflammatory response that can have pathogenic consequences for the liver.
引用
收藏
页码:786 / 795
页数:10
相关论文
共 42 条
[1]   TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER [J].
ADACHI, M ;
SUEMATSU, S ;
KONDO, T ;
OGASAWARA, J ;
TANAKA, T ;
YOSHIDA, N ;
NAGATA, S .
NATURE GENETICS, 1995, 11 (03) :294-300
[2]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[3]   Neutralizing antiviral B cell responses [J].
Bachmann, MF ;
Zinkernagel, RM .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :235-270
[4]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[5]  
Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387
[6]  
Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73
[7]   Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression [J].
Canbay, A ;
Feldstein, AE ;
Higuchi, H ;
Werneburg, N ;
Grambihler, A ;
Bronk, SF ;
Gores, GJ .
HEPATOLOGY, 2003, 38 (05) :1188-1198
[8]   A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus [J].
Chan, OTM ;
Hannum, LG ;
Haberman, AM ;
Madaio, MP ;
Shlomchik, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (10) :1639-1647
[9]   MONOCLONAL-ANTIBODIES TO PROMOTE MARROW ENGRAFTMENT AND TISSUE GRAFT TOLERANCE [J].
COBBOLD, SP ;
MARTIN, G ;
QIN, S ;
WALDMANN, H .
NATURE, 1986, 323 (6084) :164-166
[10]   Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse [J].
Dambach, DM ;
Watson, LM ;
Gray, KR ;
Durham, SK ;
Laskin, DL .
HEPATOLOGY, 2002, 35 (05) :1093-1103